Market Place
Sourcing Support
JPM26, Day 1: Updates From Lilly, Takeda, Novartis And Sofinnova
12 Jan 2026 //
FIERCE BIOTECH
Lilly, Nvidia form new AI co-innovation lab with $1B investment
12 Jan 2026 //
FIERCE BIOTECH
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Abivax shares soar 23% as media report reignites M&A Chatters
11 Jan 2026 //
REUTERS
Schrödinger Teams Up With Lilly To Launch Tunelab Platform
09 Jan 2026 //
PHARMIWEB
Chai Discovery Collaborates With Eli Lilly To Speed Up Biologics
09 Jan 2026 //
BUSINESSWIRE
Lilly Partners With Revvity To Enhance AI Drug Discovery Models
09 Jan 2026 //
PHARMIWEB
Vida Ventures Applauds Aktis Oncology`s Public Market Debut
09 Jan 2026 //
BUSINESSWIRE
Lilly touts Zepbound-Taltz combo in patients with obesity, PsA
08 Jan 2026 //
PR NEWSWIRE
Lilly, J&J Top Clarivate`s 2026 Drugs to Watch
07 Jan 2026 //
FIERCE PHARMA
Indupro Nabs 2nd Big Pharma Deal With $950M Lilly Pact
07 Jan 2026 //
BUSINESSWIRE
Lilly Acquires Ventyx Biosciences For Advancing Oral Therapies
07 Jan 2026 //
PR NEWSWIRE
Lilly in talks to buy Ventyx Biosciences for more than $1B
06 Jan 2026 //
REUTERS
Novo and Lilly Cut Prices of Weight-Loss Drugs in China
29 Dec 2025 //
REUTERS
Intense Rivalry Between Lilly And Novo Opens Up India
24 Dec 2025 //
ECONOMICTIMES
MEDI&GENE Partners With Lilly To Advance Obesity Therapeutics
17 Dec 2025 //
PR NEWSWIRE
Eli Lilly Re-Elects Nobel Laureate Carolyn Bertozzi To Board
17 Dec 2025 //
INDPHARMAPOST
Form Health Simplifies GLP-1 Coverage, Transparent Pricing
16 Dec 2025 //
BUSINESSWIRE
Lilly To Participate In J.P. Morgan Healthcare Conference
16 Dec 2025 //
PR NEWSWIRE
Lilly`s Inluriyo Shows Reinforced Efficacy in Breast Cancer
12 Dec 2025 //
PR NEWSWIRE
Lilly Shifts Oral SERD Hopes To Its Largest Oncology Trial Ever
12 Dec 2025 //
FIERCE PHARMA
Lilly`s obesity triple threat tops phase 3 efficacy forecasts
11 Dec 2025 //
PR NEWSWIRE
Lilly`s Jaypirca Boosts Progression-Free Survival By 80%
09 Dec 2025 //
PR NEWSWIRE
Lilly, Adverum Complete Tender Offer & Acquisition
09 Dec 2025 //
PR NEWSWIRE
Why Lilly Is Betting On 2nd-Line CLL Despite 1St-Line Wins
09 Dec 2025 //
FIERCE PHARMA
Lilly Selects Alabama Site as Location for $6 B API Facility
09 Dec 2025 //
FIERCE PHARMA
Lilly looks to become innovation ‘backbone,’ exec says
08 Dec 2025 //
FIERCE BIOTECH
Lilly declares first-quarter 2026 dividend
08 Dec 2025 //
PR NEWSWIRE
Carolyn Bertozzi returns to Lilly board of directors
08 Dec 2025 //
PR NEWSWIRE
Lilly`s Jaypirca Succeeds In First-Of-Its-Kind Phase 3 Study
08 Dec 2025 //
PR NEWSWIRE
Eli Lilly Commits $40M To Indiana University For Clinical Trial
04 Dec 2025 //
INDPHARMAPOST
U.S. FDA approves expanded indication for Lilly`s Jaypirca
03 Dec 2025 //
PR NEWSWIRE
Lilly, Novo Pricing Strategies Set Stage For Future Competition
03 Dec 2025 //
BIOSPACE
Lilly Urges Adverum Shareholders To Tender Shares
01 Dec 2025 //
GLOBENEWSWIRE
Eli Lilly Cuts Zepbound Price to Widen Access for Obesity Drug
01 Dec 2025 //
REUTERS
Lilly Redefines The Pharma Mega-Blockbuster
25 Nov 2025 //
BIOSPACE
Lilly Unveils Positive Jaypirca Phase 3 CLL Data at ASH 2025
24 Nov 2025 //
PR NEWSWIRE
As Vaccine Sales Declined In Q3, Lilly Thrived With 54% Growth
24 Nov 2025 //
FIERCE PHARMA
Lilly Highlights Early/Advanced HR+ BC Progress at SABCS 2025
24 Nov 2025 //
PR NEWSWIRE
Eli Lilly Becomes 1st Pharma Company to Hit US$ 1 Trillion Value
21 Nov 2025 //
REUTERS
Eli Lilly Eyes Major Impact in Obesity, Diabetes
19 Nov 2025 //
ECONOMICTIMES
Lilly To Open Gateway Labs Site In Philadelphia
19 Nov 2025 //
PR NEWSWIRE
Lilly`s Donanemab Approved By CDSCO For Alzheimer`s Disease
19 Nov 2025 //
EXPRESSPHARMA
Lilly To Participate In Citi`s 2025 Global Healthcare Conference
18 Nov 2025 //
PR NEWSWIRE
Eli Lilly, Novo Nordisk Strategize To Defend Top Obesity Drugs
18 Nov 2025 //
ECONOMICTIMES
Novo Sets New Self-Pay Prices For Wegovy, Ozempic
18 Nov 2025 //
FIERCE PHARMA
Lilly Bets $2.6B on Korean Biotech`s Bispecific Antibodies
14 Nov 2025 //
PRESS RELEASE
Lilly, Otsuka & More Earn Nods From Europe`s CHMP
14 Nov 2025 //
FIERCE PHARMA
Mangoceuticals Partners with Eli Lilly and Novo Nordisk
13 Nov 2025 //
GLOBENEWSWIRE
Eli Lilly Drops CVS Drug Plan for Workers After Novo Obesity deal
13 Nov 2025 //
REUTERS
TrumpRx, Other Initiatives Boost DTC Drug Sales
12 Nov 2025 //
BIOSPACE
Eli Lilly Ends CVS Drug Plan for Staff After Novo Obesity Deal
12 Nov 2025 //
ECONOMICTIMES
Lilly Stitches `Queer Eye` Star Into Zepbound Campaign
11 Nov 2025 //
FIERCE PHARMA
Search For Next Blockbuster Drug Extends Beyond Weight Loss
10 Nov 2025 //
BIOSPACE
Insilico, Lilly Partner For AI-Driven Drug Discovery
10 Nov 2025 //
FIERCE BIOTECH
Eli Lilly Signs Deal for MeiraGTx`s Gene Therapy for Severe Eye
10 Nov 2025 //
FIERCE BIOTECH
SanegeneBio Enters RNAi Licensing And Research Deal With Lilly
08 Nov 2025 //
PR NEWSWIRE
Lilly’s Amylin Agonist Headed to Ph3 After upto 20% Weight Loss
08 Nov 2025 //
PR NEWSWIRE
FDA Grants Priority Review Vouchers To Wegovy & Casgevy
08 Nov 2025 //
BIOSPACE
Lilly, U.S. Government Expand Access To Obesity Medicines
06 Nov 2025 //
PR NEWSWIRE
